Global Parkinson’s Disease Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Parkinson’s Disease Therapeutics market size was valued at US$ 2286.9 million in 2023. With growing demand in downstream market, the Parkinson’s Disease Therapeutics is forecast to a readjusted size of US$ 3492.3 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Parkinson’s Disease Therapeutics market. Parkinson’s Disease Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson’s Disease Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson’s Disease Therapeutics market.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
Key Features:
The report on Parkinson’s Disease Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson’s Disease Therapeutics market. It may include historical data, market segmentation by Type (e.g., Oral, Transdermal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson’s Disease Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson’s Disease Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson’s Disease Therapeutics industry. This include advancements in Parkinson’s Disease Therapeutics technology, Parkinson’s Disease Therapeutics new entrants, Parkinson’s Disease Therapeutics new investment, and other innovations that are shaping the future of Parkinson’s Disease Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson’s Disease Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson’s Disease Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson’s Disease Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson’s Disease Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson’s Disease Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson’s Disease Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson’s Disease Therapeutics market.
Market Segmentation:
Parkinson’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Parkinson’s Disease Therapeutics market size was valued at US$ 2286.9 million in 2023. With growing demand in downstream market, the Parkinson’s Disease Therapeutics is forecast to a readjusted size of US$ 3492.3 million by 2030 with a CAGR of 6.2% during review period.
The research report highlights the growth potential of the global Parkinson’s Disease Therapeutics market. Parkinson’s Disease Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Parkinson’s Disease Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Parkinson’s Disease Therapeutics market.
Parkinson's disease therapeutics includes medications and therapies used to manage the symptoms of Parkinson's disease, a neurodegenerative disorder that affects movement and motor control.
The market for Parkinson's disease therapeutics is driven by the increasing prevalence of Parkinson's disease and the demand for symptomatic relief and disease-modifying treatments. The market's growth is also influenced by ongoing research in Parkinson's disease pathophysiology and the development of novel therapeutic approaches.
Key Features:
The report on Parkinson’s Disease Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Parkinson’s Disease Therapeutics market. It may include historical data, market segmentation by Type (e.g., Oral, Transdermal), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Parkinson’s Disease Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Parkinson’s Disease Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Parkinson’s Disease Therapeutics industry. This include advancements in Parkinson’s Disease Therapeutics technology, Parkinson’s Disease Therapeutics new entrants, Parkinson’s Disease Therapeutics new investment, and other innovations that are shaping the future of Parkinson’s Disease Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Parkinson’s Disease Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Parkinson’s Disease Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Parkinson’s Disease Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Parkinson’s Disease Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Parkinson’s Disease Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Parkinson’s Disease Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Parkinson’s Disease Therapeutics market.
Market Segmentation:
Parkinson’s Disease Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Oral
- Transdermal
- Subcutaneous
- Intestinal Infusion
- Hospitals
- Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbvie
- Biogen
- Boehringer Ingelheim GmbH
- F. Hoffman-La Roche
- GlaxoSmithKline
- H. Lundbeck A/S
- Impax Labs
- Newron Pharmaceuticals SpA
- Novartis AG
- Orion Corporation
- Teva Pharmaceutical Industries Ltd.
- UCB S.A.
- Livzon Pharmaceutical
- Haisco Pharmaceutical
- Jingxin Pharmaceutical
- Dongcheng Biochemicals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size 2019-2030
2.1.2 Parkinson’s Disease Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson’s Disease Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Therapeutics Market Size by Type
2.3.1 Parkinson’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Parkinson’s Disease Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Parkinson’s Disease Therapeutics Market Size by Application
2.5.1 Parkinson’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
3 PARKINSON’S DISEASE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS BY REGIONS
4.1 Parkinson’s Disease Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.3 APAC Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.4 Europe Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
5.2 Americas Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
5.3 Americas Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Therapeutics Market Size by Region (2019-2024)
6.2 APAC Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
6.3 APAC Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Therapeutics by Country (2019-2024)
7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST
10.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson’s Disease Therapeutics Forecast
10.1.3 APAC Parkinson’s Disease Therapeutics Forecast
10.1.4 Europe Parkinson’s Disease Therapeutics Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast
10.2 Americas Parkinson’s Disease Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Parkinson’s Disease Therapeutics Market Forecast
10.2.2 Canada Parkinson’s Disease Therapeutics Market Forecast
10.2.3 Mexico Parkinson’s Disease Therapeutics Market Forecast
10.2.4 Brazil Parkinson’s Disease Therapeutics Market Forecast
10.3 APAC Parkinson’s Disease Therapeutics Forecast by Region (2025-2030)
10.3.1 China Parkinson’s Disease Therapeutics Market Forecast
10.3.2 Japan Parkinson’s Disease Therapeutics Market Forecast
10.3.3 Korea Parkinson’s Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Parkinson’s Disease Therapeutics Market Forecast
10.3.5 India Parkinson’s Disease Therapeutics Market Forecast
10.3.6 Australia Parkinson’s Disease Therapeutics Market Forecast
10.4 Europe Parkinson’s Disease Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Parkinson’s Disease Therapeutics Market Forecast
10.4.2 France Parkinson’s Disease Therapeutics Market Forecast
10.4.3 UK Parkinson’s Disease Therapeutics Market Forecast
10.4.4 Italy Parkinson’s Disease Therapeutics Market Forecast
10.4.5 Russia Parkinson’s Disease Therapeutics Market Forecast
10.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson’s Disease Therapeutics Market Forecast
10.5.2 South Africa Parkinson’s Disease Therapeutics Market Forecast
10.5.3 Israel Parkinson’s Disease Therapeutics Market Forecast
10.5.4 Turkey Parkinson’s Disease Therapeutics Market Forecast
10.5.5 GCC Countries Parkinson’s Disease Therapeutics Market Forecast
10.6 Global Parkinson’s Disease Therapeutics Forecast by Type (2025-2030)
10.7 Global Parkinson’s Disease Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbvie
11.1.1 Abbvie Company Information
11.1.2 Abbvie Parkinson’s Disease Therapeutics Product Offered
11.1.3 Abbvie Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbvie Main Business Overview
11.1.5 Abbvie Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Parkinson’s Disease Therapeutics Product Offered
11.2.3 Biogen Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered
11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer Ingelheim GmbH Main Business Overview
11.3.5 Boehringer Ingelheim GmbH Latest Developments
11.4 F. Hoffman-La Roche
11.4.1 F. Hoffman-La Roche Company Information
11.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered
11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffman-La Roche Main Business Overview
11.4.5 F. Hoffman-La Roche Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered
11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 H. Lundbeck A/S
11.6.1 H. Lundbeck A/S Company Information
11.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered
11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 H. Lundbeck A/S Main Business Overview
11.6.5 H. Lundbeck A/S Latest Developments
11.7 Impax Labs
11.7.1 Impax Labs Company Information
11.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Offered
11.7.3 Impax Labs Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Impax Labs Main Business Overview
11.7.5 Impax Labs Latest Developments
11.8 Newron Pharmaceuticals SpA
11.8.1 Newron Pharmaceuticals SpA Company Information
11.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered
11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Newron Pharmaceuticals SpA Main Business Overview
11.8.5 Newron Pharmaceuticals SpA Latest Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Offered
11.9.3 Novartis AG Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis AG Main Business Overview
11.9.5 Novartis AG Latest Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Offered
11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Orion Corporation Main Business Overview
11.10.5 Orion Corporation Latest Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Information
11.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered
11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.12 UCB S.A.
11.12.1 UCB S.A. Company Information
11.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Offered
11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 UCB S.A. Main Business Overview
11.12.5 UCB S.A. Latest Developments
11.13 Livzon Pharmaceutical
11.13.1 Livzon Pharmaceutical Company Information
11.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Livzon Pharmaceutical Main Business Overview
11.13.5 Livzon Pharmaceutical Latest Developments
11.14 Haisco Pharmaceutical
11.14.1 Haisco Pharmaceutical Company Information
11.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Haisco Pharmaceutical Main Business Overview
11.14.5 Haisco Pharmaceutical Latest Developments
11.15 Jingxin Pharmaceutical
11.15.1 Jingxin Pharmaceutical Company Information
11.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Jingxin Pharmaceutical Main Business Overview
11.15.5 Jingxin Pharmaceutical Latest Developments
11.16 Dongcheng Biochemicals
11.16.1 Dongcheng Biochemicals Company Information
11.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered
11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Dongcheng Biochemicals Main Business Overview
11.16.5 Dongcheng Biochemicals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Parkinson’s Disease Therapeutics Market Size 2019-2030
2.1.2 Parkinson’s Disease Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Parkinson’s Disease Therapeutics Segment by Type
2.2.1 Oral
2.2.2 Transdermal
2.2.3 Subcutaneous
2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Therapeutics Market Size by Type
2.3.1 Parkinson’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Parkinson’s Disease Therapeutics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Parkinson’s Disease Therapeutics Market Size by Application
2.5.1 Parkinson’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
3 PARKINSON’S DISEASE THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Parkinson’s Disease Therapeutics Market Size Market Share by Players
3.1.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Parkinson’s Disease Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PARKINSON’S DISEASE THERAPEUTICS BY REGIONS
4.1 Parkinson’s Disease Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.3 APAC Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.4 Europe Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Parkinson’s Disease Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Parkinson’s Disease Therapeutics Market Size by Country (2019-2024)
5.2 Americas Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
5.3 Americas Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Parkinson’s Disease Therapeutics Market Size by Region (2019-2024)
6.2 APAC Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
6.3 APAC Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Parkinson’s Disease Therapeutics by Country (2019-2024)
7.2 Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
7.3 Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Parkinson’s Disease Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST
10.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Parkinson’s Disease Therapeutics Forecast
10.1.3 APAC Parkinson’s Disease Therapeutics Forecast
10.1.4 Europe Parkinson’s Disease Therapeutics Forecast
10.1.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast
10.2 Americas Parkinson’s Disease Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Parkinson’s Disease Therapeutics Market Forecast
10.2.2 Canada Parkinson’s Disease Therapeutics Market Forecast
10.2.3 Mexico Parkinson’s Disease Therapeutics Market Forecast
10.2.4 Brazil Parkinson’s Disease Therapeutics Market Forecast
10.3 APAC Parkinson’s Disease Therapeutics Forecast by Region (2025-2030)
10.3.1 China Parkinson’s Disease Therapeutics Market Forecast
10.3.2 Japan Parkinson’s Disease Therapeutics Market Forecast
10.3.3 Korea Parkinson’s Disease Therapeutics Market Forecast
10.3.4 Southeast Asia Parkinson’s Disease Therapeutics Market Forecast
10.3.5 India Parkinson’s Disease Therapeutics Market Forecast
10.3.6 Australia Parkinson’s Disease Therapeutics Market Forecast
10.4 Europe Parkinson’s Disease Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Parkinson’s Disease Therapeutics Market Forecast
10.4.2 France Parkinson’s Disease Therapeutics Market Forecast
10.4.3 UK Parkinson’s Disease Therapeutics Market Forecast
10.4.4 Italy Parkinson’s Disease Therapeutics Market Forecast
10.4.5 Russia Parkinson’s Disease Therapeutics Market Forecast
10.5 Middle East & Africa Parkinson’s Disease Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Parkinson’s Disease Therapeutics Market Forecast
10.5.2 South Africa Parkinson’s Disease Therapeutics Market Forecast
10.5.3 Israel Parkinson’s Disease Therapeutics Market Forecast
10.5.4 Turkey Parkinson’s Disease Therapeutics Market Forecast
10.5.5 GCC Countries Parkinson’s Disease Therapeutics Market Forecast
10.6 Global Parkinson’s Disease Therapeutics Forecast by Type (2025-2030)
10.7 Global Parkinson’s Disease Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Abbvie
11.1.1 Abbvie Company Information
11.1.2 Abbvie Parkinson’s Disease Therapeutics Product Offered
11.1.3 Abbvie Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbvie Main Business Overview
11.1.5 Abbvie Latest Developments
11.2 Biogen
11.2.1 Biogen Company Information
11.2.2 Biogen Parkinson’s Disease Therapeutics Product Offered
11.2.3 Biogen Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Biogen Main Business Overview
11.2.5 Biogen Latest Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered
11.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer Ingelheim GmbH Main Business Overview
11.3.5 Boehringer Ingelheim GmbH Latest Developments
11.4 F. Hoffman-La Roche
11.4.1 F. Hoffman-La Roche Company Information
11.4.2 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered
11.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 F. Hoffman-La Roche Main Business Overview
11.4.5 F. Hoffman-La Roche Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered
11.5.3 GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 H. Lundbeck A/S
11.6.1 H. Lundbeck A/S Company Information
11.6.2 H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered
11.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 H. Lundbeck A/S Main Business Overview
11.6.5 H. Lundbeck A/S Latest Developments
11.7 Impax Labs
11.7.1 Impax Labs Company Information
11.7.2 Impax Labs Parkinson’s Disease Therapeutics Product Offered
11.7.3 Impax Labs Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Impax Labs Main Business Overview
11.7.5 Impax Labs Latest Developments
11.8 Newron Pharmaceuticals SpA
11.8.1 Newron Pharmaceuticals SpA Company Information
11.8.2 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered
11.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Newron Pharmaceuticals SpA Main Business Overview
11.8.5 Newron Pharmaceuticals SpA Latest Developments
11.9 Novartis AG
11.9.1 Novartis AG Company Information
11.9.2 Novartis AG Parkinson’s Disease Therapeutics Product Offered
11.9.3 Novartis AG Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Novartis AG Main Business Overview
11.9.5 Novartis AG Latest Developments
11.10 Orion Corporation
11.10.1 Orion Corporation Company Information
11.10.2 Orion Corporation Parkinson’s Disease Therapeutics Product Offered
11.10.3 Orion Corporation Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Orion Corporation Main Business Overview
11.10.5 Orion Corporation Latest Developments
11.11 Teva Pharmaceutical Industries Ltd.
11.11.1 Teva Pharmaceutical Industries Ltd. Company Information
11.11.2 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered
11.11.3 Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.11.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.12 UCB S.A.
11.12.1 UCB S.A. Company Information
11.12.2 UCB S.A. Parkinson’s Disease Therapeutics Product Offered
11.12.3 UCB S.A. Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 UCB S.A. Main Business Overview
11.12.5 UCB S.A. Latest Developments
11.13 Livzon Pharmaceutical
11.13.1 Livzon Pharmaceutical Company Information
11.13.2 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.13.3 Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Livzon Pharmaceutical Main Business Overview
11.13.5 Livzon Pharmaceutical Latest Developments
11.14 Haisco Pharmaceutical
11.14.1 Haisco Pharmaceutical Company Information
11.14.2 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.14.3 Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Haisco Pharmaceutical Main Business Overview
11.14.5 Haisco Pharmaceutical Latest Developments
11.15 Jingxin Pharmaceutical
11.15.1 Jingxin Pharmaceutical Company Information
11.15.2 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
11.15.3 Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Jingxin Pharmaceutical Main Business Overview
11.15.5 Jingxin Pharmaceutical Latest Developments
11.16 Dongcheng Biochemicals
11.16.1 Dongcheng Biochemicals Company Information
11.16.2 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered
11.16.3 Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Dongcheng Biochemicals Main Business Overview
11.16.5 Dongcheng Biochemicals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Parkinson’s Disease Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Transdermal
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intestinal Infusion
Table 6. Parkinson’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Parkinson’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Parkinson’s Disease Therapeutics Key Players Head office and Products Offered
Table 15. Parkinson’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Parkinson’s Disease Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Parkinson’s Disease Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Parkinson’s Disease Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Therapeutics
Table 47. Key Market Challenges & Risks of Parkinson’s Disease Therapeutics
Table 48. Key Industry Trends of Parkinson’s Disease Therapeutics
Table 49. Global Parkinson’s Disease Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbvie Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 54. Abbvie Parkinson’s Disease Therapeutics Product Offered
Table 55. Abbvie Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbvie Main Business
Table 57. Abbvie Latest Developments
Table 58. Biogen Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 59. Biogen Parkinson’s Disease Therapeutics Product Offered
Table 60. Biogen Main Business
Table 61. Biogen Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Biogen Latest Developments
Table 63. Boehringer Ingelheim GmbH Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 64. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered
Table 65. Boehringer Ingelheim GmbH Main Business
Table 66. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Boehringer Ingelheim GmbH Latest Developments
Table 68. F. Hoffman-La Roche Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 69. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered
Table 70. F. Hoffman-La Roche Main Business
Table 71. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. F. Hoffman-La Roche Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 74. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlaxoSmithKline Latest Developments
Table 78. H. Lundbeck A/S Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 79. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered
Table 80. H. Lundbeck A/S Main Business
Table 81. H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. H. Lundbeck A/S Latest Developments
Table 83. Impax Labs Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 84. Impax Labs Parkinson’s Disease Therapeutics Product Offered
Table 85. Impax Labs Main Business
Table 86. Impax Labs Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Impax Labs Latest Developments
Table 88. Newron Pharmaceuticals SpA Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 89. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered
Table 90. Newron Pharmaceuticals SpA Main Business
Table 91. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Newron Pharmaceuticals SpA Latest Developments
Table 93. Novartis AG Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 94. Novartis AG Parkinson’s Disease Therapeutics Product Offered
Table 95. Novartis AG Main Business
Table 96. Novartis AG Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novartis AG Latest Developments
Table 98. Orion Corporation Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 99. Orion Corporation Parkinson’s Disease Therapeutics Product Offered
Table 100. Orion Corporation Main Business
Table 101. Orion Corporation Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Orion Corporation Latest Developments
Table 103. Teva Pharmaceutical Industries Ltd. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 104. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered
Table 105. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Teva Pharmaceutical Industries Ltd. Main Business
Table 107. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 108. UCB S.A. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 109. UCB S.A. Parkinson’s Disease Therapeutics Product Offered
Table 110. UCB S.A. Main Business
Table 111. UCB S.A. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. UCB S.A. Latest Developments
Table 113. Livzon Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 114. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 115. Livzon Pharmaceutical Main Business
Table 116. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Livzon Pharmaceutical Latest Developments
Table 118. Haisco Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 119. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 120. Haisco Pharmaceutical Main Business
Table 121. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Haisco Pharmaceutical Latest Developments
Table 123. Jingxin Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 124. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 125. Jingxin Pharmaceutical Main Business
Table 126. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Jingxin Pharmaceutical Latest Developments
Table 128. Dongcheng Biochemicals Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 129. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered
Table 130. Dongcheng Biochemicals Main Business
Table 131. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Dongcheng Biochemicals Latest Developments
Table 1. Parkinson’s Disease Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Transdermal
Table 4. Major Players of Subcutaneous
Table 5. Major Players of Intestinal Infusion
Table 6. Parkinson’s Disease Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 9. Parkinson’s Disease Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 12. Global Parkinson’s Disease Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player (2019-2024)
Table 14. Parkinson’s Disease Therapeutics Key Players Head office and Products Offered
Table 15. Parkinson’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Parkinson’s Disease Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Table 20. Global Parkinson’s Disease Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Parkinson’s Disease Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 24. Americas Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 26. Americas Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 28. APAC Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 30. APAC Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 32. APAC Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 34. Europe Parkinson’s Disease Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country (2019-2024)
Table 36. Europe Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 38. Europe Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Parkinson’s Disease Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Parkinson’s Disease Therapeutics
Table 47. Key Market Challenges & Risks of Parkinson’s Disease Therapeutics
Table 48. Key Industry Trends of Parkinson’s Disease Therapeutics
Table 49. Global Parkinson’s Disease Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Parkinson’s Disease Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Parkinson’s Disease Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Abbvie Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 54. Abbvie Parkinson’s Disease Therapeutics Product Offered
Table 55. Abbvie Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Abbvie Main Business
Table 57. Abbvie Latest Developments
Table 58. Biogen Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 59. Biogen Parkinson’s Disease Therapeutics Product Offered
Table 60. Biogen Main Business
Table 61. Biogen Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Biogen Latest Developments
Table 63. Boehringer Ingelheim GmbH Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 64. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Product Offered
Table 65. Boehringer Ingelheim GmbH Main Business
Table 66. Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Boehringer Ingelheim GmbH Latest Developments
Table 68. F. Hoffman-La Roche Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 69. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Product Offered
Table 70. F. Hoffman-La Roche Main Business
Table 71. F. Hoffman-La Roche Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. F. Hoffman-La Roche Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 74. GlaxoSmithKline Parkinson’s Disease Therapeutics Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. GlaxoSmithKline Latest Developments
Table 78. H. Lundbeck A/S Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 79. H. Lundbeck A/S Parkinson’s Disease Therapeutics Product Offered
Table 80. H. Lundbeck A/S Main Business
Table 81. H. Lundbeck A/S Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. H. Lundbeck A/S Latest Developments
Table 83. Impax Labs Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 84. Impax Labs Parkinson’s Disease Therapeutics Product Offered
Table 85. Impax Labs Main Business
Table 86. Impax Labs Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Impax Labs Latest Developments
Table 88. Newron Pharmaceuticals SpA Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 89. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Product Offered
Table 90. Newron Pharmaceuticals SpA Main Business
Table 91. Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Newron Pharmaceuticals SpA Latest Developments
Table 93. Novartis AG Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 94. Novartis AG Parkinson’s Disease Therapeutics Product Offered
Table 95. Novartis AG Main Business
Table 96. Novartis AG Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Novartis AG Latest Developments
Table 98. Orion Corporation Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 99. Orion Corporation Parkinson’s Disease Therapeutics Product Offered
Table 100. Orion Corporation Main Business
Table 101. Orion Corporation Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Orion Corporation Latest Developments
Table 103. Teva Pharmaceutical Industries Ltd. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 104. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Product Offered
Table 105. Teva Pharmaceutical Industries Ltd. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Teva Pharmaceutical Industries Ltd. Main Business
Table 107. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 108. UCB S.A. Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 109. UCB S.A. Parkinson’s Disease Therapeutics Product Offered
Table 110. UCB S.A. Main Business
Table 111. UCB S.A. Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. UCB S.A. Latest Developments
Table 113. Livzon Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 114. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 115. Livzon Pharmaceutical Main Business
Table 116. Livzon Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Livzon Pharmaceutical Latest Developments
Table 118. Haisco Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 119. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 120. Haisco Pharmaceutical Main Business
Table 121. Haisco Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Haisco Pharmaceutical Latest Developments
Table 123. Jingxin Pharmaceutical Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 124. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Product Offered
Table 125. Jingxin Pharmaceutical Main Business
Table 126. Jingxin Pharmaceutical Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Jingxin Pharmaceutical Latest Developments
Table 128. Dongcheng Biochemicals Details, Company Type, Parkinson’s Disease Therapeutics Area Served and Its Competitors
Table 129. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Product Offered
Table 130. Dongcheng Biochemicals Main Business
Table 131. Dongcheng Biochemicals Parkinson’s Disease Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. Dongcheng Biochemicals Latest Developments
LIST OF FIGURES
Figure 1. Parkinson’s Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson’s Disease Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson’s Disease Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Parkinson’s Disease Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 10. Parkinson’s Disease Therapeutics in Hospitals
Figure 11. Global Parkinson’s Disease Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson’s Disease Therapeutics in Clinics
Figure 13. Global Parkinson’s Disease Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Parkinson’s Disease Therapeutics in Others
Figure 15. Global Parkinson’s Disease Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Parkinson’s Disease Therapeutics Value Market Share by Country in 2023
Figure 24. United States Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Parkinson’s Disease Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Parkinson’s Disease Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Parkinson’s Disease Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Parkinson’s Disease Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Parkinson’s Disease Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 10. Parkinson’s Disease Therapeutics in Hospitals
Figure 11. Global Parkinson’s Disease Therapeutics Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Parkinson’s Disease Therapeutics in Clinics
Figure 13. Global Parkinson’s Disease Therapeutics Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Parkinson’s Disease Therapeutics in Others
Figure 15. Global Parkinson’s Disease Therapeutics Market: Others (2019-2024) & ($ Millions)
Figure 16. Global Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 17. Global Parkinson’s Disease Therapeutics Revenue Market Share by Player in 2023
Figure 18. Global Parkinson’s Disease Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 20. APAC Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 21. Europe Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2019-2024 ($ Millions)
Figure 23. Americas Parkinson’s Disease Therapeutics Value Market Share by Country in 2023
Figure 24. United States Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Region in 2023
Figure 29. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Type in 2023
Figure 30. APAC Parkinson’s Disease Therapeutics Market Size Market Share by Application in 2023
Figure 31. China Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Country in 2023
Figure 38. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 39. Europe Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 40. Germany Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Parkinson’s Disease Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Parkinson’s Disease Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 54. APAC Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 55. Europe Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 57. United States Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 58. Canada Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 61. China Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. Japan Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Korea Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. India Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Australia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Germany Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. France Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. UK Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Italy Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Russia Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Spain Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Israel Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Parkinson’s Disease Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Parkinson’s Disease Therapeutics Market Size Market Share Forecast by Application (2025-2030)
